Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 31, 2008

View Archived Issues

1018-ISS safely combined with irinotecan-cetuximab in colorectal cancer

Study finds endoscopic ultrasound-guided delivery of BrachySil safe

Cel-Sci provides Multikine update

Avastin receives broad label extension in Europe for metastatic colorectal cancer

NPS provides update on Gattex in short bowel syndrome

Quest and BC Cancer Agency to develop photodynamic therapies for lung cancer

Sepracor acquires exclusive U.S. rights to ciclesonide

Novel therapeutic agents for infections disclosed in recent patent literature

Surface Logix achieves objectives with SLx-4090 in phase IIa trial

Velcura to initiate clinical trials following successful IND application to FDA

Bone Medical's rheumatoid arthritis drug BN-006 inhibits both IL-6 and TNF secretion

Recent AstraZeneca and GSK patents describe novel diagnostic agents

New treatments for gastrointestinal disorders reported in recent GSK and Anadys patents

Positive preclinical data on sustained-release prostacyclin analogue in PH

New HIV integrase inhibitor developed at Merck Research Laboratories

FDA grants IND clearance to Tranzyme for oral ghrelin agonist TZP-102 for gastroparesis

Lpath humanizes its monoclonal antibody Lpathomab

Lipoxen initiates phase I trial of SuliXen for type 1 and type 2 diabetes

Myriad Genetics reports positive results from phase I clinical trial of MPC-0920

Compugen reports in vivo results for two of its drug candidates

Radius launches RAD-1901 clinical program for the treatment of hot flashes

FDA issues complete response letter for Lev Pharmaceuticals' Cinryze

BTG commences first clinical study of novel migraine treatment

Nuvelo commences phase I NU-172 trial

LX-201 granted fast track designation for corneal transplant rejection

EMEA to review GlaxoSmithKline pneumococcal Haemophilus pediatric vaccine

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...